Next Article in Journal
Molecular Evolution of Dengue Virus 3 in Senegal between 2009 and 2022: Dispersal Patterns and Implications for Prevention and Therapeutic Countermeasures
Previous Article in Journal
Understanding Prognostic Factors for Human Papillomavirus Vaccination: A Rural Community Case–Control Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 11
Issue 10
10.3390/vaccines11101538
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Vaccines 2023, 11(4), 715.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175

by
Phoom Narongkiatikhun
1,
Kajohnsak Noppakun
1,
Romanee Chaiwarith
2,
Poramed Winichakoon
2,
Surachet Vongsanim
1,
Yuttitham Suteeka
1,
Karn Pongsuwan
1,
Prit Kusirisin
1,
Nuttanun Wongsarikan
3,
Kanda Fanhchaksai
4,
Chantana Khamwan
5,
Dararat Dankai
5 and
Vuddhidej Ophascharoensuk
1,*
1
Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
2
Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
3
Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
4
Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
5
Immunology Laboratory, Diagnostic Laboratory, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
*
Author to whom correspondence should be addressed.
Vaccines 2023, 11(10), 1538; https://doi.org/10.3390/vaccines11101538
Submission received: 11 August 2023 / Accepted: 14 September 2023 / Published: 28 September 2023
(This article belongs to the Section COVID-19 Vaccines and Vaccination)
Versions Notes
The authors wish to make the following correction to this paper [1]:
In the original publication, in “Section 2.1. Study Design and Participants”, there was a mistake in the initial date of patient recruitment, which should be 4 June 2021, instead of 1 June 2021. The corrected date appears below:
“We conducted a single-center, observational prospective cohort study involving MHD patients between 4 June and 31 December 2021 at Maharaj Nakorn Chiang Mai Hospital, which is an affiliated hospital of Chiang Mai University, Thailand.”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Narongkiatikhun, P.; Noppakun, K.; Chaiwarith, R.; Winichakoon, P.; Vongsanim, S.; Suteeka, Y.; Pongsuwan, K.; Kusirisin, P.; Wongsarikan, N.; Fanhchaksai, K.; et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 715. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Narongkiatikhun, P.; Noppakun, K.; Chaiwarith, R.; Winichakoon, P.; Vongsanim, S.; Suteeka, Y.; Pongsuwan, K.; Kusirisin, P.; Wongsarikan, N.; Fanhchaksai, K.; et al. Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175. Vaccines 2023, 11, 1538. https://doi.org/10.3390/vaccines11101538

AMA Style

Narongkiatikhun P, Noppakun K, Chaiwarith R, Winichakoon P, Vongsanim S, Suteeka Y, Pongsuwan K, Kusirisin P, Wongsarikan N, Fanhchaksai K, et al. Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175. Vaccines. 2023; 11(10):1538. https://doi.org/10.3390/vaccines11101538

Chicago/Turabian Style

Narongkiatikhun, Phoom, Kajohnsak Noppakun, Romanee Chaiwarith, Poramed Winichakoon, Surachet Vongsanim, Yuttitham Suteeka, Karn Pongsuwan, Prit Kusirisin, Nuttanun Wongsarikan, Kanda Fanhchaksai, and et al. 2023. "Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175" Vaccines 11, no. 10: 1538. https://doi.org/10.3390/vaccines11101538

APA Style

Narongkiatikhun, P., Noppakun, K., Chaiwarith, R., Winichakoon, P., Vongsanim, S., Suteeka, Y., Pongsuwan, K., Kusirisin, P., Wongsarikan, N., Fanhchaksai, K., Khamwan, C., Dankai, D., & Ophascharoensuk, V. (2023). Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175. Vaccines, 11(10), 1538. https://doi.org/10.3390/vaccines11101538

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop